Silence Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLN and other ETFs, options, and stocks.

About SLN

Silence Therapeutics Plc engages in the discovery, delivery, and development of ribonucleic acid (RNA) therapeutics. It also develops medicines by harnessing the body's natural mechanism of RNA interference within its cells.

CEO

Craig Allen Tooman

CEOCraig Allen Tooman

Employees

116

Employees116

Headquarters

London, Greater London

HeadquartersLondon, Greater London

Founded

1994

Founded1994

Employees

116

Employees116

SLN Key Statistics

Market cap

250.79M

Market cap250.79M

Price-Earnings ratio

-3.18

Price-Earnings ratio-3.18

Dividend yield

—

Dividend yield—

Average volume

63.19K

Average volume63.19K

High today

$5.64

High today$5.64

Low today

$5.27

Low today$5.27

Open price

$5.64

Open price$5.64

Volume

49.62K

Volume49.62K

52 Week high

$20.48

52 Week high$20.48

52 Week low

$1.97

52 Week low$1.97

Silence Therapeutics

Why Robinhood?

Silence Therapeutics Plc engages in the discovery, delivery, and development of ribonucleic acid (RNA) therapeutics. It also develops medicines by harnessing the body's natural mechanism of RNA interference within its cells. Show more

SLN Key Statistics

Silence Therapeutics Plc engages in the discovery, delivery, and development of ribonucleic acid (RNA) therapeutics. It also develops medicines by harnessing the body's natural mechanism of RNA interference within its cells.